• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday

    8/11/22 5:28:25 AM ET
    $ABCL
    $ADV
    $AFRM
    $ALC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate
    Real Estate
    Get the next $ABCL alert in real time by email

    Gainers

    • Invitae Corporation (NYSE:NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.
    • BioAtla, Inc. (NASDAQ:BCAB) jumped 83.1% to close at $6.61 on Wednesday following Q2 results.
    • Allego N.V. (NYSE:ALLG) gained 57.1% to settle at $5.83 amid volatility in low-float former SPAC names.
    • Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) rose 49% to close at $4.62.
    • Velo3D, Inc. (NYSE:VLD) shares jumped 42.3% to close at $5.08 after reporting upbeat Q2 results.
    • Amyris, Inc. (NASDAQ:AMRS) rose 41.9% to settle at $3.25. The stock may be rebounding after falling Tuesday on Q2 results.
    • Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) rose 39.2% to close at $1.03 after the company reported better-than-expected Q2 EPS results.
    • Euro Tech Holdings Company Limited (NASDAQ:CLWT) gained 38.4% to close at $2.02.
    • Velodyne Lidar, Inc. (NASDAQ:VLDR) gained 38.3% to close at $1.59. The company recently posted upbeat quarterly results.
    • Liberty TripAdvisor Holdings, Inc. (NASDAQ:LTRPA) surged 37.9% to close at $1.27.
    • The Trade Desk, Inc. (NASDAQ:TTD) jumped 36.2% to close at $74.24 after the company reported better-than-expected Q2 sales results and issued Q3 sales guidance above estimates. Additionally, multiple analysts raised their price target on the stock.
    • V2X, Inc. (NYSE:VVX) jumped 34.1% to close at $39.96 following upbeat Q2 results. Stifel upgraded V2X from Hold to Buy and raised the price target from $42 to $45.
    • Bionano Genomics, Inc. (NASDAQ:BNGO) gained 32.7% to settle at $3.00. Bionano Genomics recently posted Q2 sales of $6.70 million.
    • OraSure Technologies, Inc. (NASDAQ:OSUR) shares climbed 32.3% to close at $4.22 after the company reported upbeat Q2 sales and issued strong sales outlook for the current quarter.
    • Biora Therapeutics, Inc. (NASDAQ:BIOR) gained 31.2% to close at $1.01. Biora Therapeutics disclosed successful completion of device performance study in ulcerative colitis patients for its targeted therapeutics platform.
    • PLx Pharma Inc. (NASDAQ:PLXP) surged 31.1% to settle at $2.57.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) gained 30.6% to close at $0.1580 after declining around 7% on Tuesday.
    • Chicken Soup for the Soul Entertainment, Inc. (NASDAQ:CSSE) surged 30% to $14.75.
    • Seer, Inc. (NASDAQ:SEER) gained 29.6% to close at $13.31 after the company reported better-than-expected Q2 EPS and sales results..
    • Array Technologies, Inc. (NASDAQ:ARRY) climbed 28.9% to close at $23.58 after the company reported better-than-expected Q2 adjusted EPS and sales results.
    • Model N, Inc. (NYSE:MODN) jumped 28.9% to close at $33.77 after the company posted upbeat Q3 results and issued strong FY22 forecast.
    • Gemini Therapeutics, Inc. (NASDAQ:GMTX) jumped 28.9% to settle at $2.01. Gemini Therapeutics and privately held Disc Medicine Inc have entered into a merger agreement in an all-stock transaction.
    • CleanSpark, Inc. (NASDAQ:CLSK) surged 27.8% to settle at $5.98 following Q3 results.
    • LiveVox Holdings, Inc. (NASDAQ:LVOX) gained 27.4% to close at $2.51 following Q2 results.
    • Performance Shipping Inc. (NASDAQ:PSHG) jumped 25.6% to close at $0.5150.
    • Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) surged 25.3% to close at $3.37 following Q2 results.
    • Doma Holdings Inc. (NYSE:DOMA) gained 25% to settle at $0.8751 following Q2 results.
    • Sunworks, Inc. (NASDAQ:SUNW) jumped 24.4% to close at $3.83. Sunworks reported better-than-expected Q2 sales results.
    • Inovio Pharmaceuticals, Inc. (NASDAQ:INO) gained 23.8% to close at $2.60 after the company reported better-than-expected Q2 sales results.
    • Quanergy Systems, Inc. (NYSE:QNGY) rose 23.4% to close at $0.4076 as the company received multi-million dollar order from Prime Secured.
    • BARK, Inc. (NYSE:BARK) gained 20.9% to settle at $2.14 following better-than-expected Q1 results.
    • Emerald Holding, Inc. (NYSE:EEX) jumped 20.9% to close at $3.99 following Q2 results.
    • Porch Group, Inc. (NASDAQ:PRCH) gained 20.5% to close at $2.88 following Q2 results.
    • AbCellera Biologics Inc. (NASDAQ:ABCL) rose 20.1% to close at $13.34 after the company reported Q2 earnings results.
    • AcuityAds Holdings Inc. (NASDAQ:ATY) rose 18.6% to close at $3.00 following Q2 earnings.
    • Xometry, Inc. (NASDAQ:XMTR) gained 18.5% to close at $49.70 as the company posted a narrower Q2 loss.
    • Bloom Energy Corporation (NYSE:BE) rose 18.3% to close at $29.30 after the company reported better-than-expected Q2 sales results. Following earnings, multiple firms maintained bullish ratings and raised their price target on the stock.
    • Nortech Systems Incorporated (NASDAQ:NSYS) climbed 18.2% to close at $12.12 after the company reported Q2 sales results were up year over year.
    • Upstart Holdings, Inc. (NASDAQ:UPST) surged 17.8% to close at $33.50. Upstart recently reported worse-than-expected Q2 EPS and sales results.
    • CarLotz, Inc. (NASDAQ:LOTZ) shares jumped 17.8% to close at $0.6669 after the company reported financial results and announced a merger agreement with Shift Technologies Inc.
    • LifeStance Health Group, Inc. (NASDAQ:LFST) jumped 17.3% to settle at $7.86 after reporting Q2 results.
    • Synalloy Corporation (NASDAQ:SYNL) gained 17.2% to close at $15.57 after reporting a sharp rise in quarterly earnings.
    • Plug Power Inc. (NASDAQ:PLUG) gained 16.7% to close at $28.78 after the company reported Q2 earnings results. Following earnings, multiple firms maintained bullish ratings on the stock and raised their price target.
    • Homology Medicines, Inc. (NASDAQ:FIXX) climbed 16.7% to settle at $2.86.
    • Vuzix Corporation (NASDAQ:VUZI) gained 16.6% to close at $9.55 after the company reported better-than-expected Q2 sales results.
    • Alta Equipment Group Inc. (NYSE:ALTG) gained 16.6% to close at $13.22 after the company reported better-than-expected Q2 adjusted EPS and sales results.
    • Shoals Technologies Group, Inc. (NASDAQ:SHLS) rose 15.9% to settle at $26.62.
    • Codere Online Luxembourg, S.A. (NASDAQ:CDRO) rose 15.3% to close at $2.94.
    • H&R Block, Inc. (NYSE:HRB) climbed 15.3% to close at $45.47 after the company reported Q4 sales results were higher year over year. The company also issued FY23 adjusted EPS and revenue guidance above estimates.
    • Pangaea Logistics Solutions, Ltd. (NASDAQ:PANL) gained 14.4% to close at $5.55 following upbeat Q2 results.
    • Enfusion, Inc. (NYSE:ENFN) gained 13.6% to close at $14.94 following strong quarterly sales.
    • Axon Enterprise, Inc. (NASDAQ:AXON) rose 13% to close at $126.07 after the company reported better-than-expected Q2 EPS and sales results and raised FY22 revenue guidance.
    • Affirm Holdings, Inc. (NASDAQ:AFRM) rose 12.9% to settle at $36.78.
    • Flywire Corporation (NASDAQ:FLYW) gained 12.8% to close at $26.65 after the company reported better-than-expected Q2 sales results and issued Q3 and FY22 revenue guidance above estimates.
    • Bill.com Holdings, Inc. (NYSE:BILL) gained 12.1% to settle at $162.51.
    • Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) rose 12.1% to close at $13.56 as the stock rebounded after falling Tuesday on weak Q3 earnings. A better-than-expected CPI report has improved economic sentiment and lifted discretionary sectors such as travel.
    • SentinelOne, Inc. (NYSE:S) gained 12% to close at $28.11.
    • Qualtrics International Inc. (NASDAQ:XM) rose 11.6% to close at $15.37.
    • HubSpot, Inc. (NYSE:HUBS) jumped 11.6% to close at $407.07. HubSpot recently reported better-than-expected Q2 adjusted EPS and sales results.
    • SilverSun Technologies, Inc. (NASDAQ:SSNT) shares rose 10.6% to close at $4.07 after jumping over 19% on Tuesday.
    • Workiva Inc. (NYSE:WK) rose 10.6% to close at $75.75 after the company reported better-than-expected Q2 EPS and sales results and issued FY22 revenue guidance above estimates.
    • Shopify Inc. (NYSE:SHOP) gained 10.5% to settle at $40.61.
    • Unity Software Inc. (NYSE:U) jumped 10.3% to close at $55.57. The stock initially traded lower Tuesday evening after the company reported mixed financial results, but it has since recovered amid positive analyst coverage and an overall market rebound.
    • TuSimple Holdings Inc. (NASDAQ:TSP) gained 10.3% to close at $9.98.
    • Super Micro Computer, Inc. (NASDAQ:SMCI) rose 9.5% to close at $63.73 after the company reported better-than-expected Q4 EPS and sales results.
    • CyberArk Software Ltd. (NASDAQ:CYBR) jumped 8.2% to settle at $149.74 after the company reported better-than-expected Q2 EPS and sales results.
    • Coinbase Global, Inc. (NASDAQ:COIN) gained 7.4% to close at $94.14 amid strength in cryptocurrencies. The company, however, reported a wider-than-expected loss for its second quarter and also shared an updated full year guidance.
    • Twitter, Inc. (NYSE:TWTR) rose 3.7% to close at $44.43 after Tesla CEO Elon Musk sold shares of the electric vehicle company, noting that the funds could be used for a potential Twitter deal. Wedbush raised the price target on Twitter from $30 to $50.


    Losers

    • Redbox Entertainment Inc. (NASDAQ:RDBX) dipped 52.9% to close at $1.65 on Wednesday after the company said its stockholders approved merger with Chicken Soup for the Soul Entertainment, Inc.
    • IsoPlexis Corporation (NASDAQ:ISO) fell 30% to close at $2.10 after the company reported worse-than-expected Q2 sales results,
    • OptimizeRx Corporation (NASDAQ:OPRX) shares dipped 30% to close at $15.57 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.
    • BigBear.ai Holdings, Inc. (NYSE:BBAI) shares fell 27% to close at $2.00 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.
    • Bonso Electronics International Inc. (NASDAQ:BNSO) tumbled 27% to settle at $4.2250.
    • Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) fell 26.7% to close at $4.11 after the company reported Q2 EPS results were down year over year.
    • WM Technology, Inc. (NASDAQ:MAPS) shares dipped 25.1% to close at $2.59 after the company reported worse-than-expected Q2 sales results. Additionally, multiple analysts downgraded and lowered their price target on the stock.
    • Nextdoor Holdings, Inc. (NASDAQ:KIND) fell 25% to close at $2.70 after the company reported downbeat Q2 results and issued weak Q3 forecast.
    • Evofem Biosciences, Inc. (NASDAQ:EVFM) declined 23.4% to $0.4782. Evofem Biosciences on August 9, received written notice from the Nasdaq that it has determined to delist co.'s securities from Nasdaq Capital Market.
    • VYNE Therapeutics Inc. (NASDAQ:VYNE) dropped 22.9% to settle at $0.3120 as the company announced results from the Phase 2a segment of a Phase 1b/2a clinical trial evaluating FMX114 for the treatment of mild-to-moderate atopic dermatitis (AD).
    • Singular Genomics Systems, Inc. (NASDAQ:OMIC) fell 22.7% to close at $3.44 following Q2 results. Goldman Sachs and B of A Securities also downgraded the stock.
    • Tuesday Morning Corporation (NASDAQ:TUEM) dipped 22.7% to settle at $0.34.
    • Repay Holdings Corporation (NASDAQ:RPAY) dropped 20.8% to close at $10.25 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.
    • American Public Education, Inc. (NASDAQ:APEI) declined 20.4% to settle at $12.47 after the company reported Q2 EPS results were down year over year and worse-than-expected Q2 sales results and issued Q3 sales guidance below estimates.
    • Centerra Gold Inc. (NYSE:CGAU) fell 20.1% to close at $4.92. Centerra Gold announced a quarterly dividend of C$0.07 per common share.
    • Organogenesis Holdings Inc. (NASDAQ:ORGO) dropped 20% to settle at $4.81 after the company issued FY22 sales guidance below analyst estimates.
    • SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) fell 18.1% to close at $29.49. SpringWorks Therapeutics recently posted a Q2 loss of $1.41 per share.
    • PLBY Group, Inc. (NASDAQ:PLBY) shares fell 17.2% to close at $5.78 after the company reported worse-than-expected Q2 EPS and sales results.
    • PetIQ, Inc. (NASDAQ:PETQ) fell 16.9% to close at $14.12 after the company posted downbeat Q2 sales and issued weak sales forecast.
    • CAE Inc. (NYSE:CAE) fell 16.7% to close at $21.48 after the company reported worse-than-expected Q1 adjusted EPS results.
    • Rackspace Technology, Inc. (NASDAQ:RXT) dropped 15.7% to close at $2.70 after the company reported worse-than-expected Q2 sales results and issued Q3 sales guidance below estimates. Additionally, Raymond James downgraded the stock from Outperform to Market Perform.
    • Angi Inc. (NASDAQ:ANGI) dropped 15.3% to close at $5.20 after the company reported Q2 earnings results.
    • TTEC Holdings, Inc. (NASDAQ:TTEC) fell 15.1% to settle at $60.34 after the company issued Q3 and FY22 revenue guidance below estimates.
    • Cano Health, Inc. (NYSE:CANO) declined 13.2% to close at $4.74 after the company reported worse-than-expected Q2 sales results
    • XP Inc. (NASDAQ:XP) dipped 13.2% to close at $20.53 following Q2 results.
    • Bright Health Group, Inc. (NYSE:BHG) fell 11.9% to close at $1.71 after the company reported worse-than-expected Q2 EPS and sales results.
    • Certara, Inc. (NASDAQ:CERT) dipped 10.9% to close at $20.36 after the company reported worse-than-expected Q2 adjusted EPS and sales results and issued FY22 adjusted EPS and sales guidance below estimates.
    • Advantage Solutions Inc. (NASDAQ:ADV) fell 8% to close at $3.92 after the company reported worse-than-expected Q2 sales results.
    • Evotec SE (NASDAQ:EVO) fell 6.8% to close at $13.13. Evotec Biologics and Alpine Immune Sciences expanded partnership for commercial process development of ALPN-303.
    • Alcon Inc. (NYSE:ALC) shares fell 4.7% to close at $71.94 after the company reported Q2 results.
    Get the next $ABCL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABCL
    $ADV
    $AFRM
    $ALC

    CompanyDatePrice TargetRatingAnalyst
    Affirm Holdings Inc.
    $AFRM
    4/22/2026$75.00Outperform
    BMO Capital Markets
    Flywire Corporation Voting
    $FLYW
    4/16/2026$17.00Neutral → Buy
    BTIG Research
    V2X Inc.
    $VVX
    4/16/2026$74.00Equal-Weight
    Morgan Stanley
    Evotec SE
    $EVO
    4/15/2026$7.00Buy
    H.C. Wainwright
    Bloom Energy Corporation
    $BE
    4/14/2026$187.00Underperform → Hold
    Jefferies
    Coinbase Global Inc.
    $COIN
    4/8/2026$140.00Equal Weight → Underweight
    Barclays
    HubSpot Inc.
    $HUBS
    3/31/2026$300.00Buy
    BofA Securities
    Olema Pharmaceuticals Inc.
    $OLMA
    3/27/2026Peer Perform
    Wolfe Research
    More analyst ratings

    $ABCL
    $ADV
    $AFRM
    $ALC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Mcgrath Kenneth J bought $66,030 worth of shares (22,021 units at $3.00), increasing direct ownership by 4% to 557,262 units (SEC Form 4)

    4 - ORASURE TECHNOLOGIES INC (0001116463) (Issuer)

    3/16/26 8:01:53 PM ET
    $OSUR
    Medical/Dental Instruments
    Health Care

    President & CEO Eglinton Manner Carrie bought $66,033 worth of shares (22,022 units at $3.00), increasing direct ownership by 1% to 2,158,574 units (SEC Form 4)

    4 - ORASURE TECHNOLOGIES INC (0001116463) (Issuer)

    3/16/26 8:01:38 PM ET
    $OSUR
    Medical/Dental Instruments
    Health Care

    Director Nair Sidhartha bought $27,250 worth of shares (4,000 units at $6.81), increasing direct ownership by 12% to 37,806 units (SEC Form 4)

    4 - ALTA EQUIPMENT GROUP INC. (0001759824) (Issuer)

    3/16/26 6:11:12 PM ET
    $ALTG
    Industrial Machinery/Components
    Industrials

    $ABCL
    $ADV
    $AFRM
    $ALC
    SEC Filings

    View All

    SEC Form 6-K filed by Evotec SE

    6-K - Evotec SE (0001412558) (Filer)

    4/24/26 6:03:13 AM ET
    $EVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEFA14A filed by Flywire Corporation Voting

    DEFA14A - Flywire Corp (0001580560) (Filer)

    4/23/26 4:28:38 PM ET
    $FLYW
    Real Estate

    SEC Form DEF 14A filed by Flywire Corporation Voting

    DEF 14A - Flywire Corp (0001580560) (Filer)

    4/23/26 4:26:20 PM ET
    $FLYW
    Real Estate

    $ABCL
    $ADV
    $AFRM
    $ALC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Radoff-JEC Group Submits Improved Non-Binding Proposal to Acquire Seer, Inc.

    Proposal Provides Stockholders $2.35 per Share in Cash, a 39% Premium to the Unaffected Closing Price, as Well as Potential Additional Value from the Sale of Seer's Assets via a Contingent Value Right Proposal Provides Stockholders Immediate and Significant Value While Avoiding Further Value Destruction from Continued Abysmal Operating Results Criticizes the Board for Failing to Engage With the Radoff-JEC Group Regarding its Acquisition Proposal Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the "Radoff-JEC Group"), who collectively own approximately 7.6% of the outstanding shares of Seer, Inc. (NASDAQ:SEER) ("Seer" or the "Company"), today submitted t

    4/24/26 7:00:00 AM ET
    $SEER
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    HubSpot to Announce First Quarter 2026 Financial Results on May 7, 2026

    HubSpot, the agentic customer platform for scaling businesses, announced today that it will report its first quarter 2026 financial results after the U.S. financial markets close on Thursday, May 7, 2026. In conjunction with this report, HubSpot will host a conference call at 4:30 p.m. Eastern Time (ET) on the same day to discuss the company's first quarter 2026 financial results and its business operations and outlook. HubSpot First Quarter 2026 Financial Results When: Thursday, May 7, 2026 Time: 4:30 p.m. ET Conference Call Registration: Dial-in Link Webcast: Webcast Link To participate via telephone, please register in advance. Upon registration, participants will receive a confirma

    4/23/26 4:05:00 PM ET
    $HUBS
    Computer Software: Prepackaged Software
    Technology

    Xometry to Announce First Quarter 2026 Financial Results on May 7, 2026

    NORTH BETHESDA, Md., April 23, 2026 (GLOBE NEWSWIRE) -- Xometry, Inc. (NASDAQ:XMTR), the global AI-native marketplace connecting buyers and suppliers of custom manufacturing, today announced it will report its first quarter 2026 financial results before the market opens on May 7, 2026. Xometry will host its conference call and webcast to discuss the results at 8:30 a.m. ET (5:30 a.m. PT) on the same day. In addition to its press release announcing its first quarter 2026 financial results, Xometry will also release an earnings presentation, which will be available on its Investor Relations website. Xometry, Inc. Q1 2026 Earnings Presentation and Conference Call Thursday, May 7, 20268:30

    4/23/26 9:05:00 AM ET
    $XMTR
    Real Estate

    $ABCL
    $ADV
    $AFRM
    $ALC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on Affirm with a new price target

    BMO Capital Markets initiated coverage of Affirm with a rating of Outperform and set a new price target of $75.00

    4/22/26 7:55:46 AM ET
    $AFRM
    Finance: Consumer Services
    Finance

    Flywire upgraded by BTIG Research with a new price target

    BTIG Research upgraded Flywire from Neutral to Buy and set a new price target of $17.00

    4/16/26 7:58:27 AM ET
    $FLYW
    Real Estate

    Morgan Stanley resumed coverage on V2X with a new price target

    Morgan Stanley resumed coverage of V2X with a rating of Equal-Weight and set a new price target of $74.00

    4/16/26 7:54:24 AM ET
    $VVX
    Diversified Commercial Services
    Consumer Discretionary

    $ABCL
    $ADV
    $AFRM
    $ALC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 27, 2023 - FDA Approves First Therapy for Rare Type of Non-Cancerous Tumors

    For Immediate Release: November 27, 2023 Today, the U.S. Food and Drug Administration approved Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment. Ogsiveo is the first drug to be approved for the treatment of patients with desmoid tumors, a rare subtype of soft tissue sarcomas. Desmoid tumors are non-cancerous but can be locally aggressive. The tumor

    11/27/23 5:34:21 PM ET
    $SWTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for OGSIVEO issued to SPRINGWORKS THERAPEUTICS INC

    Submission status for SPRINGWORKS THERAPEUTICS INC's drug OGSIVEO (ORIG-1) with active ingredient NIROGACESTAT has changed to 'Approval' on 11/27/2023. Application Category: NDA, Application Number: 217677, Application Classification: Type 1 - New Molecular Entity

    11/27/23 5:34:04 PM ET
    $SWTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABCL
    $ADV
    $AFRM
    $ALC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, CHAIRMAN AND FOUNDER Ehrlichman Matt sold $983,952 worth of shares (121,242 units at $8.12), decreasing direct ownership by 0.71% to 16,928,071 units (SEC Form 4) to satisfy withholding tax

    4 - Porch Group, Inc. (0001784535) (Issuer)

    4/23/26 6:08:21 PM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    Chief Operating Officer Neagle Matthew sold $509,668 worth of shares (62,801 units at $8.12), decreasing direct ownership by 2% to 2,485,878 units (SEC Form 4) (tax liability)

    4 - Porch Group, Inc. (0001784535) (Issuer)

    4/23/26 6:07:32 PM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    CHIEF FINANCIAL OFFICER Tabak Shawn sold $62,734 worth of shares (7,730 units at $8.12), decreasing direct ownership by 2% to 382,559 units (SEC Form 4) (withholding obligation)

    4 - Porch Group, Inc. (0001784535) (Issuer)

    4/23/26 6:06:09 PM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    $ABCL
    $ADV
    $AFRM
    $ALC
    Leadership Updates

    Live Leadership Updates

    View All

    OraSure Technologies Appoints John D. Bertrand to its Board of Directors

    Enters into Cooperation Agreement with Altai Capital Board to Seek Shareholder Approval for Declassification at the 2026 Annual Meeting BETHLEHEM, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. ("OraSure" and "OTI") (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the appointment of John D. Bertrand to its Board of Directors as an independent director, effective immediately. Mr. Bertrand is a healthcare technology executive with more than a decade of experience driving AI-enabled innovation in diagnostics. He co-founded Digital Diagnostics Inc. and most recently served as its Chief Executive Officer,

    4/16/26 8:10:00 PM ET
    $OSUR
    Medical/Dental Instruments
    Health Care

    Myomo Appoints William J Febbo to its Board of Directors

    Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of William "Will" Febbo as a director effective April 14, 2026, to serve until the 2028 annual meeting of stockholders. With this appointment, Myomo has six directors. Mr. Febbo is an accomplished executive, entrepreneur, and investor with over 30 years of experience in healthcare, financial services, and technology-driven businesses. He has successfully guided organizations through substantial growth, strategic transformations and acquisitions, and significant ca

    4/16/26 4:05:00 PM ET
    $MYO
    $OPRX
    Industrial Specialties
    Health Care
    Real Estate

    REPAY Announces New Consumer Payments Leader

    Repay Holdings Corporation (NASDAQ:RPAY) ("REPAY" or the "Company"), a leading provider of integrated payment processing solutions, today announced the appointment of Matt Morrow as the new executive leader of Consumer Payments, effective May 12, 2026. Matt will lead REPAY's Consumer Payments overall strategy, overseeing the segment's growth, sales, and operational initiatives across REPAY's consumer finance verticals, including personal lending, automative loans, accounts receivable management, healthcare and mortgage servicing. In his new role, Matt will report to John Morris, REPAY's CEO. Matt brings over a decade of payments and business services experience managing divisional busines

    4/16/26 4:05:00 PM ET
    $RPAY
    Real Estate

    $ABCL
    $ADV
    $AFRM
    $ALC
    Financials

    Live finance-specific insights

    View All

    HubSpot to Announce First Quarter 2026 Financial Results on May 7, 2026

    HubSpot, the agentic customer platform for scaling businesses, announced today that it will report its first quarter 2026 financial results after the U.S. financial markets close on Thursday, May 7, 2026. In conjunction with this report, HubSpot will host a conference call at 4:30 p.m. Eastern Time (ET) on the same day to discuss the company's first quarter 2026 financial results and its business operations and outlook. HubSpot First Quarter 2026 Financial Results When: Thursday, May 7, 2026 Time: 4:30 p.m. ET Conference Call Registration: Dial-in Link Webcast: Webcast Link To participate via telephone, please register in advance. Upon registration, participants will receive a confirma

    4/23/26 4:05:00 PM ET
    $HUBS
    Computer Software: Prepackaged Software
    Technology

    Xometry to Announce First Quarter 2026 Financial Results on May 7, 2026

    NORTH BETHESDA, Md., April 23, 2026 (GLOBE NEWSWIRE) -- Xometry, Inc. (NASDAQ:XMTR), the global AI-native marketplace connecting buyers and suppliers of custom manufacturing, today announced it will report its first quarter 2026 financial results before the market opens on May 7, 2026. Xometry will host its conference call and webcast to discuss the results at 8:30 a.m. ET (5:30 a.m. PT) on the same day. In addition to its press release announcing its first quarter 2026 financial results, Xometry will also release an earnings presentation, which will be available on its Investor Relations website. Xometry, Inc. Q1 2026 Earnings Presentation and Conference Call Thursday, May 7, 20268:30

    4/23/26 9:05:00 AM ET
    $XMTR
    Real Estate

    Norwegian Cruise Line Holdings to Hold Conference Call on First Quarter 2026 Financial Results

    MIAMI, April 23, 2026 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) (together with NCL Corporation Ltd., "Norwegian Cruise Line Holdings" or the "Company") announced today it will report first quarter 2026 financial results on Monday, May 4, 2026 at 6:30 a.m. Eastern Time with a conference call and webcast to discuss results at 8:30 a.m. Eastern Time. The conference call will be webcast via the Company's Investor Relations website, https://www.nclhltd.com/investors. A replay of the webcast will be available here on the Company's website for 30 days following the call. About Norwegian Cruise Line Holdings Ltd. Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) is a lea

    4/23/26 8:30:00 AM ET
    $NCLH
    Marine Transportation
    Consumer Discretionary

    $ABCL
    $ADV
    $AFRM
    $ALC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/16/24 9:09:02 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by SentinelOne Inc.

    SC 13D/A - SentinelOne, Inc. (0001583708) (Subject)

    12/12/24 6:30:27 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/12/24 4:17:36 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology